Registration is now open for the Oklahoma Mothers and Newborns Affected by Opioids (OMNO) collaborative. The goal of this collaborative is to Develop a standardized approach to identify and treat pregnant women with opioid use disorder as well as opioid-exposed newborns. OPQIC will select a small number of hospitals to participate in a pilot program in early 2020. Registration for this collaborative is a criteria for recognition as a Spotlight Hospital for 2019. Registration closes on August 31, 2019. For more information and to register, see the informational brochure.